At the inaugural Yangtze River Delta AI & Healthcare Innovation Conference, Suzhou First Affiliated Hospital and Surgerii Robotics were honored for their pioneering work in robotic thoracic surgery using China’s first single-port robotic system, SHURUI®.
The team has completed complex procedures—including lobectomy, segmentectomy, and bronchial sleeve resections—with 100% success, zero conversions, and outstanding outcomes. Notably, in April 2025, Prof. Jun Zhao’s team completed the world’s first cross-continental robotic lobectomy using the SHURUI® system and 5G connectivity—linking China and Romania in a real-time operation with <80ms delay.
Experts at the event praised the team’s technical leadership, noting it as a breakthrough for China’s high-end surgical technology. Looking ahead, the hospital will expand robotic research into esophageal and mediastinal surgeries, advancing AI-integrated, ultra-minimally invasive care across the region.
Important Notes
The Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has been approved by the National Medical Products Administration (NMPA) in China for urology and gynecology laparoscopic surgeries. Surgeons who wish to learn the surgical operations of the SHURUI robot should contact Beijing Surgerii Robotics Co., Ltd. to participate in the official training program. Patients who want to participate in the registered clinical trials of the SHURUI robot should contact the official cooperative hospitals of Surgerii and consult with surgeons to determine their suitability for surgery with the SHURUI robot. Both surgeons and patients should carefully understand all information regarding the performance of surgeries by the SHURUI robot and its potential risks.
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other
trademarks and may not be used without permission.
